Specify a stock or a cryptocurrency in the search bar to get a summary
Annexin Pharmaceuticals AB
ANNXAnnexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden. Address: Kammakargatan 48, Stockholm, Sweden, 111 60
Analytics
WallStreet Target Price
18.47 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ANNX
Dividend Analytics ANNX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ANNX
Stock Valuation ANNX
Financials ANNX
Results | 2019 | Dynamics |